Skip to main content

Testicular Cancer clinical trials at UC Cancer

2 research studies open to eligible people

Showing trials for
  • A Study of miRNA 371 in Patients With Germ Cell Tumors

    open to eligible people ages 18 years and up

    This trial studies whether the blood marker micro ribonucleic acid (miRNA) 371 can predict the chance of cancer returning in patients with germ cell cancers. Studying samples of blood from patients with germ cell cancers in the laboratory may help doctors predict how likely the cancer will come back.

    at UC Irvine UCSD

  • Active surveillance, chemotherapy in treating pediatric and adult patients with germ cell tumors

    “How well does chemotherapy, (bleomycin, carboplatin, etoposide, or cisplatin), active surveillance work in patients with germ cell tumors?”

    open to eligible people ages up to 49 years

    This phase III trial studies how well active surveillance, bleomycin, carboplatin, etoposide, or cisplatin work in treating pediatric and adult patients with germ cell tumors. Active surveillance may help doctors to monitor subjects with low risk germ cell tumors after their tumor is removed. Drugs used in chemotherapy, such as bleomycin, carboplatin, etoposide, and cisplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading.

    at UC Davis UCLA UCSF

Last updated: